Results for tag: "Fanconi Syndrome"

Fanconi Syndrome is a rare genetic disorder that affects the kidneys and other organs. It is characterized by the inability of the kidneys to properly reabsorb electrolytes and other essential nutrients, leading to a variety of symptoms including excessive urination, dehydration, and bone and muscle weakness. In the context of Urology and Nephrology, Fanconi Syndrome is a major area of research and treatment. The market for Fanconi Syndrome is largely focused on the development of new treatments and therapies. Pharmaceutical companies are researching and developing drugs to treat the disorder, while medical device companies are developing new technologies to diagnose and monitor the condition. Additionally, research institutions are conducting clinical trials to better understand the disorder and develop new treatments. Some companies in the Fanconi Syndrome market include AbbVie, AstraZeneca, GlaxoSmithKline, Novartis, Pfizer, and Sanofi. Show Less Read more